1-3 of 3
H.G. van der Poel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Short-Term Outcome after Cystectomy: Comparison of Two Different Perioperative Protocols

Available to Purchase
Subject Area:
Further Areas
R.R. de Vries, P. Kauer, H. van Tinteren, H.G. van der Poel, A. Bex, W. Meinhardt, E.P. van Haarst, S. Horenblas
Journal: Urologia Internationalis
Urol Int (2012) 88 (4): 383–389.
https://doi.org/10.1159/000336155
Published Online: 14 March 2012
View article titled, Short-Term Outcome after Cystectomy: Comparison of Two Different Perioperative Protocols
Open the PDF for Short-Term Outcome after Cystectomy: Comparison of Two Different Perioperative Protocols in another window
Journal Articles

Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells

Available to Purchase
Subject Area:
Further Areas
H.G. van der Poel, J. Zevenhoven, A.M. Bergman
Journal: Urologia Internationalis
Urol Int (2010) 84 (2): 212–220.
https://doi.org/10.1159/000277601
Published Online: 04 March 2010
View article titled, Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells
Open the PDF for Pim1 Regulates Androgen-Dependent Survival Signaling in Prostate Cancer Cells in another window
Journal Articles

Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
H.G. van der Poel, N. Antonini, C.A. Hoefnagel, S. Horenblas, R.A. Valdes Olmos
Journal: Urologia Internationalis
Urol Int (2006) 77 (1): 50–56.
https://doi.org/10.1159/000092935
Published Online: 12 May 2009
View article titled, Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer
Open the PDF for Serum Hemoglobin Levels Predict Response to Strontium-89 and Rhenium-186-HEDP Radionuclide Treatment for Painful Osseous Metastases in Prostate Cancer in another window